In the News
Christine Lemke on Evidation’s Push to Use Wearables in Healthcare
On a recent episode of the Moneyball Medicine podcast, host Harry Glorikian interviewed Evidation Co-CEO Chrstine Lemke on what Evidation does, its history, and how its work has evolved since the company started. Smart devices like Fitbits and Apple Watches are with us all the time, and so much of the time the data...
2021 Best Tech Startups in San Mateo
Evidation Health is one of the 10 tech startups honored by The Tech Tribune as being the best tech startups in San Mateo, California. The publication considered factors including revenue potential, leadership team, brand/product traction, and competitive landscape. In order to qualify for the list, companies must be...
Augmedix Launches Tech-Enabled Service Within Emergency Departments to Provide Real-Time Support and Optimize Clinician Workflows
Augmedix, a provider of remote medical documentation and live clinical support, is announcing a rollout of a tech-enabled medical documentation service powered by virtual scribes and created specifically for busy Emergency Department (ED) environments, Augmedix trains remotely located scribes in emergency medicine...
AI-Enabled Scribes and Entrepreneurship with Ian Shakil (Augmedix)
On a recent episode of the AI Health Podcast, Augmedix Founder, Director, and Chief Strategy Officer Ian Shakil sat down to discuss how Augmedix is changing how electronic health records are generated, saving doctors time and improving patient experience. He also tells the story of how he founded Augmedix, and how...
Accolade to Acquire 2nd.MD
Accolade, a company that provides personalized solutions that help people better understand, navigate, and use the healthcare system and their workplace benefits, has signed a definitive agreement to acquire Innovation Specialists, LLC (d/b/a 2nd.MD), a leading expert medical opinion and decision support company....
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease
GRAIL today announced a collaboration with global biopharmaceutical companies Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate GRAIL’s methylation-based technology for the detection of minimal residual disease (MRD). Cancer MRD testing is used in clinical and research applications to detect the presence or...
GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
GRAIL has confirmed that it expects to introduce Galleri™, its multi-cancer early detection blood test, in the second quarter of 2021. In December 2020, GRAIL completed the enrollment of PATHFINDER, a prospective, 6,600-participant multi-site interventional study conducted under a U.S. Food and Drug Administration...
McKesson Ventures Expands Portfolio Development Team and Invests in Market Research
McKesson Ventures has added Lizzie Lee as its newest team member. She joins the firm as senior director, leading its portfolio development and market research efforts. With a decade of healthcare experience, Lee is well-positioned to help McKesson Ventures’ portfolio companies scale by developing and facilitating...
Aspen RxHealth Raises $23M Series B Funding Round Led by Bessemer Venture Partners
Aspen RxHealth, developer of a first-of-its-kind clinical pharmacy model developed by pharmacists for pharmacists that delivers value for health plans and risk-bearing providers, today announced the closure of a $23 million Series B funding round led by Bessemer Venture Partners, with participation from other...
The Future of Care Demands a Virtual Health Ecosystem
Telehealth usage skyrocketed in the early stages of the COVID-19 pandemic. According to data from EHR vendor Epic Systems, telehealth visits peaked in mid-April, when telehealth accounted for 69 percent of all ambulatory care visits. Although the percentage dropped to 21 percent by mid-July, telehealth usage is still...
Press Releases
Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence
McKesson Ventures portfolio company Aetion is one of the five real-world data (RWD) and analytics organizations that have banded together to form the RWE Alliance, an industry coalition dedicated to advancing the use of real-world evidence (RWE) to support regulatory...
Aetion Closes $110M Series C Funding Round Led by Warburg Pincus
On May 11, Aetion announced a $110 million Series C fundraise. The fundraise was led by growth equity firm Warburg Pincus, with additional funding from new investors B Capital and Foresite Capital and existing investors New Enterprise Associates (NEA) and Flare...
Augmedix to Report 2021 First Quarter Financial Results on May 13, 2021
Augmedix, a leading provider of remote medical documentation and live clinical support, has announced that it will report financial results for the first quarter 2021 on Thursday, May 13, 2021, after market close. Company management will host a corresponding...
Pharmapacks Announces Expansion and Reformation of Board of Directors and Advisors
Pharmapacks, an eCommerce enablement platform and retail seller for brands across major eCommerce marketplaces, announced that it has a new Board of Directors and Advisors, effective January 2021. The announcement follows Pharmapacks’ partnership with and strategic...
Accolade to Acquire PlushCare
Accolade announced that it has signed a definitive agreement to acquire PlushCare, a leading provider of virtual primary care and mental health treatment. Together, the two companies intend to provide more seamless consumer access to care for acute, chronic, and...